Annual Lung SPORE Workshop (Overview)


The Lung Cancer SPORE annual meeting will take place June 12-13, 2023 in Boston, MA. The meeting will be hosted by the Dana-Farber/Harvard Cancer Center Lung SPORE group led by Drs. David Barbie and Lecia Sequist and will continue the tradition of reporting on the latest developments in lung cancer translational research.   We always look forward to a strong Patient, Research and Community Advocates, as well as NCI, representation.

As an NIH supported meeting, the organizers encourage the promotion of diverse and inclusive participation in all aspects of the meeting, including the agenda. 

The agenda will be created based on the abstracts associated with each session. This year, we anticipate a significant number of abstracts. As such, abstracts will be reviewed by the scientific committee to decide whether the abstract will be presented orally or by poster presentation. Selected abstracts or posters will require in-person attendance. Tentatively, the SPORE meeting will have the following sessions:

Session 1: Driver Oncogene Addiction
Session 2: Health Disparities in Lung Cancer
Session 3: Novel Immunotherapeutic Clinical Approaches
Session 4: Tumor Immune Interactions
Session 5: Cancer Biology
Session 6: Lung Cancer Risk and early Detection
Session 7: Potpourri
Session 8: SCLC


Mass General Brigham, Assembly Row
Markell Room ABC
399 Revolution Drive
Somerville, MA 02145
(COVID restrictions are in place)

A Zoom link will be sent to registered attendees


June 12-13, 2023

Should you have any questions about the agenda, please contact Drs. David Barbie and Lecia Sequist.  Questions about meeting logistics should be directed to Ahn Tran.  Questions on the registration, abstract or poster submissions should be directed to Tamara Walton

Meeting Deadlines:

Registration opens: February 24, 2023
In-Person Registration closes: May 26, 2023

Virtual Registration closes: June 5, 2023

Abstracts open: February 24, 2023
Abstracts close: March 27, 2023

We look forward to a robust and collaborative meeting.